Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Prevest DenproBOM:543363 +0.78%84 Operating Margin % is 33.81% as of Mar. 2026, which is 6% above its 10-year median of 31.82. GuruFocus rates BOM:543363 with a GF Score™ of 84/100 and a GF Value™ of ₹622.13 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Prevest Denpro ranks better than 95.95% on this metric.
Prevest Denpro Ltd operating margin has been in a 5-year decline. The average rate of decline per year is -1.8%.
The historical rank and industry rank for Prevest Denpro's Operating Margin % or its related term are showing as below:
BOM:543363'
s Operating Margin % Range Over the Past 10 Years
Min: 18.01 Med: 31.82 Max: 38.57
Current: 31.61
BOM:543363's Operating Margin % is ranked better than 95.95% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 3.17
vs BOM:543363: 31.61
Prevest Denpro's 5-Year Average Operating Margin % Growth Rate was -1.80% per year.
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Prevest Denpro Operating Margin % Related Terms
Prevest Denpro Operating Margin % Historical Data
* Premium members only.
The historical data trend for Prevest Denpro's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543363 vs ISRG, BDX, MDLN: Operating Margin % Comparison
For the Medical Instruments & Supplies subindustry, Prevest Denpro's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prevest Denpro Operating Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Prevest Denpro's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Prevest Denpro's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Prevest Denpro's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prevest Denpro (BOM:543363) has a Operating Margin % of 33.81% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Prevest Denpro and its competitors. This is near median its historical median of 31.82. Over the past decade, Prevest Denpro's Operating Margin % has ranged from 18.01 to 38.57. According to the industry distribution chart, Prevest Denpro ranks #33 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 4%.
Is Prevest Denpro's Operating Margin % too high?
Prevest Denpro's current Operating Margin % of 33.81% is near median its 10-year median of 31.82. Over the past 10 years, this metric has ranged from a low of 18.01 to a high of 38.57. The Medical Devices & Instruments industry median Operating Margin % is 3.17. Prevest Denpro's value of 33.81% is 966.6% above this industry median. Based on the distribution chart, Prevest Denpro ranks #33 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Prevest Denpro has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Prevest Denpro's Operating Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Prevest Denpro ranks #33 out of 815 companies for Operating Margin %. This places Prevest Denpro in the top 4% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 3.17. Prevest Denpro's value of 33.81% is 966.6% above this benchmark. Historically, Prevest Denpro's own Operating Margin % has ranged from 18.01 to 38.57 over the past decade. While the company's 10-year median is 31.82 vs. the industry median of 3.17, Prevest Denpro has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.17, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Prevest Denpro's current Operating Margin % of 33.81% is 966.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Prevest Denpro and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prevest Denpro's current Operating Margin % is 33.81%, which is near median its own 10-year median of 31.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prevest Denpro stock overvalued right now?
Based on GuruFocus' analysis, Prevest Denpro (BOM:543363) is currently considered Possible Value Trap. The stock's GF Value™ is ₹622.13, compared to a current price of ₹390.00 — trading 37.3% below its estimated fair value. The current Operating Margin % is 33.81%, which is near median its 10-year median of 31.82 and 966.6% above the Medical Devices & Instruments industry median of 3.17. Prevest Denpro's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Prevest Denpro (BOM:543363), the current Operating Margin % is 33.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Prevest Denpro (BOM:543363) Overvalued in 2026?
Based on GuruFocus' analysis, Prevest Denpro stock appears to be undervalued.
The current stock price of ₹390.00 is trading 37.3% below its estimated GF Value™ of ₹622.13.
GuruFocus considers Prevest Denpro to be Possible Value Trap.
Key valuation signals for BOM:543363:
Operating Margin %: 33.81% (near median its 10-year median of 31.82)
GF Value™: ₹622.13 vs. price of ₹390.00 (37.3% below fair value)
Industry Position: 966.6% above the Medical Devices & Instruments median (#33 of 815)
No single metric tells the full story. See the BOM:543363 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Prevest Denpro Ltd develops, manufactures and markets a comprehensive portfolio of dental materials for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. The company's product portfolio covers wide spectrum of materials for endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and laboratory consumables.
84GF Score
Get the complete analysis for BOM:543363
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543363 has been successfully added to your 
